Simcere Pharmaceutical Group Ltd (2096)

Hong Kong

Currency in HKD

12.31

-0.17(-1.36%)

Closed·08:59:59

Fair Value

Unlock Value

Day's Range

12.16

12.60

52 wk Range

5.08

14.28

2096 Financial Summary

A brief financial summary of Simcere Pharmaceutical Group Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio38.33

Price/Book3.91

Debt / Equity17.11%

Return on Equity10.26%

Dividend Yield1.40%

EBITDA1.36B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2011

31/12

2012

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

4,508.72

4,999.72

6,324.08

6,607.81

6,635.21

Gross Profit

aa.aa

3,608.79

3,919.74

4,996.68

4,984.15

5,324.58

Operating Income

aa.aa

599.91

233.33

606.34

710.84

1,133.28

Net Income

aa.aa

669.53

1,507.1

930.87

714.76

733.17

Balance Sheet

Total Assets

aa.aa

10,943.41

10,161.14

10,788.95

10,853.67

11,509.93

Total Current Liabilities

aa.aa

3,497.16

3,063.76

2,966.62

2,685.9

2,726.98

Total Equity

aa.aa

5,335.72

6,462.76

7,147.77

7,222.74

7,068.12

Cash Flow

Levered Free Cash Flow

aa.aa

-1,095.67

438.89

175.48

-1,045.08

453.05

Cash from Operations

aa.aa

96.73

-201.97

1,354.1

151.05

1,391.12

Cash from Investing

aa.aa

529.08

-435.5

68.31

1,087.81

-1,050.09

Cash from Financing

aa.aa

2,353.62

-1,624.53

-753.68

-894.83

-407.4

Net Change in Cash

aa.aa

2,915.44

-2,297.1

683.85

348.85

-64.09

* In Millions of CNY (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 0.29%

Dividend Yield

1.40%

Industry Median 2.40%

Annualised payout

0.17

Paid annually

5-Years Growth

Growth Streak

Unlock

Analyst Ratings

4 Buy

1 Hold

0 Sell

Ratings:

5 analysts

Overall Consensus

Strong Buy

Analysts 12-Month Price Target:

Average 13.64

(+10.77% Upside)

Earnings

Latest Release

Apr 28, 2025

EPS / Forecast

0.11 / --

Revenue / Forecast

3.52B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Simcere's earnings for the latest quarter?

The Simcere EPS (TTM) is 0.29. Simcere reported sales of 3,521.69, net income of 276.57, and EPS of 0.11 for the latest quarter.

What was Simcere's net income for the latest quarter?

Simcere's net income for the latest quarter was 276.57.

How did Simcere's performance compare year-over-year in the latest quarter?

The company's revenue moved from 3,113.52 in the previous quarter to 3,521.69 in the latest quarter, and net income moved from 456.60 to 276.57 compared to the previous quarter.

What is Simcere's net profit margin on a TTM basis?

Simcere's trailing twelve months (TTM) net profit margin is 11.05%.

How does Simcere's debt to equity ratio compare to industry standards?

Simcere's total debt-to-equity ratio is 17.11%.

What is Simcere's return on investment on a TTM basis?

Simcere's trailing twelve months (TTM) return on investment (ROI) is 10.26%.

Did Simcere gain or lose cash last quarter?

In the latest quarter, Simcere's net change in cash was -811.91 million.

What were Simcere's total assets and liabilities in the latest quarter?

As of the latest quarter, Simcere reported total assets of 11,509.93 million and total liabilities of 2,726.98 million.

How has Simcere's total revenue grown this year?

Simcere's total revenue was 3,113.52 in the previous quarter and 3,521.69 in the latest quarter.

What is Simcere's gross margin on a TTM basis?

Simcere's trailing twelve months (TTM) gross margin is 80.25%.

What was Simcere's revenue per share for the latest quarter?

Simcere's revenue per share for the latest quarter was 5.27.

NSE 30

5,319.36

-45.68

-0.85%

NSE All Share

145,539.20

-1,031.48

-0.70%

US 30

44,048.10

+79.4

+0.18%

US 500

6,355.30

+15.3

+0.24%

FTSE 100

9,090.65

-10.12

-0.11%

DAX

24,169.79

-20.91

-0.09%

South Africa Top 40

93,605.03

+299.26

+0.32%

Market Movers

Name	Last	Chg. %	Vol.
Linkassure	2.06	+9.57%	585.28M
Access Holdings	27.60	+0.73%	34.83M
UBA	48.50	+0.10%	22.84M
Zenith Bank	74.15	-0.74%	14.75M
Guaranty Trust Holding	99.65	-0.30%	10.61M
Dangote Cement	530.10	-8.13%	9.86M
MTN Nigeria	454.70	-5.27%	3.27M

Name	Last	Chg. %	Vol.
Union Dicon Salt	9.90	+10.00%	122.75K
Universal Insurance PLC	1.10	+10.00%	169.78M
Mansard Ins	14.640	+9.99%	5.46M
Austin Laz	2.32	+9.95%	1.87M
Ikeja	21.950	+6.55%	1.11M
Cornerst	6.41	+9.95%	13.64M
Abbey Mortgage Bank	7.68	+9.87%	629.55K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	5.29K
Juli	9.00	-10.00%	40.78K
Unilever Nigeria	71.75	-9.97%	3.29M
BUA Cement	158.00	-9.71%	1.37M
Omatek Ventures	1.34	-7.59%	9.98M
Honeywell Flour Mills Plc	24.150	-8.87%	3.14M
Transcorp Power	265.00	-7.99%	626.26K

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	3.50	+9.72%	159.85M
Jaiz Bank	4.52	-3.83%	9.73M
Access Holdings	27.55	+0.55%	34.81M
Linkassure	2.06	+9.57%	585.28M
Chams	2.80	-3.45%	10.30M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaaa Aaa	543.00	+39.94%	759.87
Aaaaaaa	70.00	+22.46%	85.72
Aaaaaa A	595.00	+10.85%	659.56

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Simcere Pharmaceutical Group Ltd (2096)

2096 Financial Summary

Key Ratios

Statements Highlights

Dividends

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were Simcere's earnings for the latest quarter?

What was Simcere's net income for the latest quarter?

How did Simcere's performance compare year-over-year in the latest quarter?

What is Simcere's net profit margin on a TTM basis?

How does Simcere's debt to equity ratio compare to industry standards?

What is Simcere's return on investment on a TTM basis?

Did Simcere gain or lose cash last quarter?

What were Simcere's total assets and liabilities in the latest quarter?

How has Simcere's total revenue grown this year?

What is Simcere's gross margin on a TTM basis?

What was Simcere's revenue per share for the latest quarter?

Trending Stocks